1743.3
-30.50 (-1.72%)
ACUTAAS • 02 Dec, 2025 | 01:29 PM
1Y Annualised Return
▲106.64%
3Y Annualised Return
▲41.93%
Acutaas Chemicals Stock Performance
|
|
|
Acutaas Chemicals Company background
Founded in: 2007
Acutaas Chemicals Limited was initially formed as partnership firm in the name of Ami Organics on 3 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under the name of Ami Organics Private Limited with a Certificate of Incorporation dated 12 June, 2007. Subsequently, the Company was converted into a Public Limited Company, reflecting the change in name of the Company to Ami Organics Limited on April 18, 2018. The name of the Company has now changed to Acutaas Chemicals Limited with effect from May 15, 2025, pursuant to the receipt of Fresh Certificate of Incorporation from the Registrar of Companies. The Company is engaged in business of drugs intermediate chemicals and related activities. The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Company Implemented the Integrated Management System (IMS) in 2011 it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 5050 JV in 2015. It increased warehouse capacity, equipped with modern infrastructure a storage capacity of 1,050 MT of RM in 2017.The Company commenced its new Solvent Recovery Plant at Sachin in 2020. It acquired two units namely, the Ankleshwar and Jhagadia units from Gujarat Organics Limited (GOL) in 2021. The Company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders, mopped up with a total of Rs 570 crore through its public issue in September, 2021. The Company incorporated wholly owned subsidiary Ami Organics Electrolytes Private Limited in 2023. The Company further embarked on setting brownfield project at Ankleshwar entailing a capex of Rs. 1900 Million. The existing Ankleshwar facility was demolished and work started to set up a new plant with advance technology for pharma intermediates business, scheduled to have installed capacity of 436.5 KL.The Company acquired a 55% stake in Baba Fine Chemicals (BFC) in FY 2024. The stateoftheart technology driven plant in Ankleshwar Unit with the total reactor capacity of 442 KL for the manufacture of advanced pharmaceutical intermediate business with Distributed Control System (DCS) technology is made fully operational in FY 2025.
Acutaas Chemicals Financial Highlights
Acutaas Chemicals reported a Q2 FY 2025-26
revenue of ₹306.2 crore,
up 41.2% YoY,
with net profit increased
229.3% to ₹71.86 crore. For the full year FY2025–2026, revenue
reached ₹1023.8 crore and profit touched at
₹160.42 crore. As of Sep '25, Acutaas Chemicals’s market capitalisation stood at ₹14,272.59 crores.
Shareholding as of Sep '25 shows promoters holding 32.7%, with FIIs at
16.8%, DIIs at 22.6%, and public at 27.9%.
Acutaas Chemicals Share Price Today
As of 2 Dec 2025, Acutaas Chemicals share price is ₹1743.3. The stock opened at ₹1767.1 and had closed at ₹1773.8 the previous day. During today’s trading session, Acutaas Chemicals share price moved between ₹1,735.70 and ₹1,767.10, with an average price for the day of ₹1751.40. Over the last 52 weeks, the stock has recorded a low of ₹918.78 and a high of ₹1,902.00. In terms of performance, Acutaas Chemicals share price has increased by 48.2% over the past six months and has increased by 106.64% over the last year.
Acutaas Chemicals SIP Return Calculator
Over the past
1 year
3 years
Total Investment of ₹1,80,000
Monthly SIP of ₹5,000 would have become ₹3,61,837 in 3 years with a gain of ₹1,81,837 (+101.02%)
Acutaas Chemicals Fundamental
Market Cap (in crs)
14,272.59
Face Value
5
Turnover (in lacs)
3,438.19
Key Metrics
Qtr Change %
89.74% Gain from 52W Low
23.3
Dividend yield 1yr %
Low in industry
0.1
Acutaas Chemicals Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Acutaas Chemicals Quarterly Revenue
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
306.2 Cr | 207.24 Cr | 308.48 Cr | 274.99 Cr | 246.73 Cr |
Acutaas Chemicals Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
1023.8 Cr | 724.97 Cr | 621.05 Cr | 522.9 Cr | 341.99 Cr | 242.49 Cr |
Acutaas Chemicals Quarterly Net Profit/Loss
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
71.86 Cr | 44.01 Cr | 62.72 Cr | 45.45 Cr | 37.57 Cr |
Acutaas Chemicals Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
160.42 Cr | 48.71 Cr | 83.29 Cr | 71.95 Cr | 54 Cr | 27.47 Cr |
Acutaas Chemicals Result Highlights
Result Summary
-
Acutaas Chemicals Ltd reported a 41.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 23.9%.
-
Its expenses for the quarter were up by 33.2% QoQ and 7.2% YoY.
-
The net profit increased 63.3% QoQ and increased 91.3% YoY.
-
The earnings per share (EPS) of Acutaas Chemicals Ltd stood at 8.82 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Acutaas Chemicals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1743.3
Current Price
Day EMA5
1,775.80
Day EMA10
1,771.90
Day EMA12
1,768.30
Day EMA20
1,748.50
Day EMA26
1,729.90
Day EMA50
1,650.20
Day EMA100
1,519.00
Day EMA200
1,351.70
Day SMA5
1,787.60
Day SMA10
1,774.90
Day SMA20
1,758.10
Day SMA30
1,750.50
Day SMA50
1,627.50
Day SMA100
1,475.10
Day SMA150
1,362.30
Day SMA200
1,309.10
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 95282 Rs | 201127 Rs |
Week Rs | 95295 Rs | 223840 Rs |
Month Rs | 173511 Rs | 393285 Rs |
Resistance & Support
1,748.70
Pivot
Resistance
First Resistance
1,761.70
Second Resistance
1,780.10
Third Resistance
1,793.10
Support
First Support
1,730.30
Second support
1,717.30
Third Support
1,698.90
Relative Strength Index
51.72
Money Flow Index
62.81
MACD
38.42
MACD Signal
45.10
Average True Range
66.93
Average Directional Index
30.71
Rate of Change (21)
0.90
Rate of Change (125)
54.71
Acutaas Chemicals Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,919.40 | 14,589.68 | 1599 | 2641 | 1,909.10 | 0.76% | -5.58% | -11.13% | -14.16% | 152.20% | 0.31% | 41.79 | 41.73 | 7.93 | |
570.20 | 13,836.97 | 422 | 628 | 568.75 | 4.45% | 0.81% | 7.76% | -4.18% | 67.90% | 0.26% | 38.23 | 41.73 | 3.90 | |
1,098.40 | 17,497.51 | 802 | 1265 | 1,108.60 | 0.97% | -0.24% | -6.10% | -8.64% | 190.01% | 0.46% | 0.00 | 41.73 | 7.78 | |
932.55 | 16,702.89 | 726.8 | 1505 | 903.20 | 11.82% | 13.74% | 6.20% | -34.10% | 60.25% | 0.64% | 11.01 | 41.73 | 2.02 | |
886.30 | 10,873.25 | 850 | 1251 | 904.60 | 0.18% | -2.01% | -14.33% | -17.29% | 104.90% | 0.56% | 20.50 | 41.73 | 3.61 | |
4,621.50 | 10,643.60 | 4537.45 | 5894.5 | 4,616.20 | -3.53% | -4.57% | -14.89% | -3.71% | 0.00% | 1.19% | 49.56 | 41.73 | 41.43 |
Acutaas Chemicals Share Price FAQs
What is Share Price of Acutaas Chemicals ?
Acutaas Chemicals share price is ₹1743.3 in NSE and ₹1744.5 in BSE as on 2/12/2025.
How has Acutaas Chemicals shares performed in the past ?
Acutaas Chemicals share price in the past 1-year return was 54.3. The Acutaas Chemicals share hit a 1-year low of Rs. 918.78 and a 1-year high of Rs. 1902.
What is the market cap of Acutaas Chemicals ?
The market cap of Acutaas Chemicals is Rs. 14272.59 Cr. as of 2/12/2025.
What is the current P/E ratio of Acutaas Chemicals ?
The PE ratios of Acutaas Chemicals is 63.28 as of 2/12/2025.
What is the current PB ratio of Acutaas Chemicals ?
The PB ratios of Acutaas Chemicals is 10.08 as of 2/12/2025
What is the Mutual Fund shareholding in Acutaas Chemicals ?
The Mutual Fund Shareholding in Acutaas Chemicals was 15.81% at the end of 2/12/2025.
How to buy Acutaas Chemicals shares?
You can easily buy Acutaas Chemicals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Acutaas Chemicals ?
The 52-week high and low of Acutaas Chemicals share price is ₹1902 and ₹918.78 as of 2/12/2025.
What is the EPS of Acutaas Chemicals ?
The earnings per share (EPS) of Acutaas Chemicals stood at 8.82 during Q2 FY 2025-26.
Please be aware that Acutaas Chemicals stock prices are subject to continuous fluctuations due to various factors.
Invest in Acutaas Chemicals